The Maternal Infant Child and Youth Research Network is a federal not-for-profit, charitable organization founded in 2006 to build capacity for high-quality applied health research. It now links 21 maternal and child health research organizations based at academic health centres in Canada; is affiliated with more than 20 practice-based research networks; provides support to new and emerging teams; and has established strong national and international partnerships. A large amount of research is conducted by teams with investigators based at multiple sites across Canada. Often these groups work independently, in silos, but deal with similar issues and face barriers to conducting multijurisdictional research. MICYRN is working to address these challenges. MICYRN is unique in the world for this type of collaborative engagement. Working together in a coordinated fashion enables the sharing of innovations and reduces duplication of effort and resource use, which means more funds can be spent on doing research.
External link for MICYRN
950 West 28th Ave
Rm V2-230
Vancouver, BC V5Z 4H4, CA
MICYRN reposted this
We are hiring! The CHEO Research Institute is a leading hospital based Institute which conducts internationally competitive pediatric research. Our focus is to support new discoveries that inspire the best life for every child and youth. #research #hiring #hospital #healthcare We’re #hiring. Know anyone who might be interested?
The funding of #RareKids-CAN is mentioned in OrphaNews International! #rarediseases
We are hiring! Come join the team at MICYRN, we are looking for the best and brightest minds to support the newly launched #RareKids-CAN Platform #clinicaltrials #research #projectmanagement #qualityassurance https://lnkd.in/gUpXKxJQ
MICYRN reposted this
Every year in Canada, around 14,000 children die from a rare disease. That is why the Government of Canada, through the Canadian Institutes of Health Research, is investing $20M in the creation of a national pediatric rare disease clinical trials and treatments network. This initiative will be lead by Dr. Thierry Lacaze-Masmonteil and his team. Read more on our website: https://lnkd.in/gdXbttrc #raredisease #rareillness #immunodeficiency #immunedeficiency #ThinkZebras #NothingWithoutUs
MICYRN is thrilled to announce its success in securing a $20 million grant from CIHR Institute of Genetics to support the development and execution of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network. Under the leadership of MICYRN’s Scientific Director, and Nominated Principal Applicant, Dr. Thierry Lacaze-Masmonteil, RareKids-CAN is a transformative initiative set to revolutionize the landscape of rare disease research and treatment for children and their families in Canada and beyond.
Meet Dr. Thierry Lacaze-Masmonteil, the lead principal investigator for the newly funded National Pediatric Rare Disease Clinical Trials and Treatments Network. Dr. Lacaze-Masmonteil and his team of experts in rare diseases, genetics and pediatrics, as well as patient partners, will receive $20M over five years to create a network that will streamline rare disease clinical research in Canada to provide a better health outcome for children living with a rare disease. https://lnkd.in/ewShFbDi . Voici le Dr Thierry Lacaze-Masmonteil, chercheur principal du Réseau national d’essais cliniques sur les maladies infantiles rares et leur traitement, nouvellement financé. Le Dr Lacaze-Masmonteil et son équipe d’experts dans les domaines des maladies rares, de la génétique et de la pédiatrie, ainsi que des patients partenaires, recevront 20 M$ sur cinq ans pour créer un réseau qui facilitera la recherche clinique sur les maladies rares au Canada afin d’améliorer le sort des enfants atteints. https://lnkd.in/eVanz5Tx
We're #hiring a new Clinical Trial Monitor in Canada. Apply today or share this post with your network.